IPO Profile: ProNAi Therapeutics Inc

The Michigan company, which develops cancer-fighting drugs, raised a $137.7 million IPO

1 August 2015•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.